Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
THIRD GLOBAL IRON DEFICIENCY DAY TO RAISE AWARENESS OF THE SYMPTOMS OF IRON DEFICIENCY | |||||||||||||||||
By: Nasdaq / GlobeNewswire - 23 Nov 2017 | Back to overview list |
||||||||||||||||
THIS COMING SUNDAY IS IRON DEFICIENCY DAY, A DAY DEDICATED TO RECOGNISING THE MANY SYMPTOMS OF IRON DEFICIENCY, WHICH, ACCORDING TO THE WORLD HEALTH ORGANIZATION (WHO), AFFECTS 30 PERCENT OF THE WORLD'S POPULATION. 3 ONE OF THE MAIN BARRIERS PREVENTING SUCCESSFUL DIAGNOSIS IS SIMPLY RECOGNIZING THE SYMPTOMS OF IRON DEFICIENCY AND IRON DEFICIENCY ANAEMIA TO BEGIN WITH. 1,4 Iron deficiency is a health-related condition in which iron availability is insufficient to meet the body's needs and which can be present with or without anaemia. 1 Iron is essential for the healthy functioning of the whole body, including that of the heart, muscles and red blood cells. 1,5 It is also important for optimum mental and physical health, and to keep energy levels up. 6,7,8 The WHO recognises as much as a 30% reduction of physical work output and performance in iron-deficient men and women. 9 Despite its prevalence, many people do not recognize the symptoms of iron deficiency 10 and obtaining a correct diagnosis is challenging. 1,4 Luisa Avedano, CEO of EFCCA (The European Federation of Crohn's and Ulcerative Colitis Associations) commented: "For people with ulcerative colitis (UC) or Crohn's disease (CD), iron deficiency and iron deficiency anaemia are common problems. Symptoms such as persistent fatigue and lack of energy can have a significant impact on quality of life, so effective management of the iron levels is important as a part of the wider management of UC and CD. Iron Deficiency Day 2017 should help by prompting people to get checked if they suspect they may have any symptom of iron deficiency." With its accompanying international communication campaign featuring easily understood explanations of the various symptoms in approachable character form, Iron Deficiency Day 2017 aims to help people recognize the symptoms of iron deficiency. Symptoms suggesting iron deficiency are generally vague and can be associated with a number of clinical conditions. Symptoms highly suggestive of iron deficiency include generalized fatigue, often independent of anaemia, and ingestion of non-nutritive materials such as clay, dirt, paper, ice, and others (pica). Other common symptoms include brittle nails, hair loss, and restless legs syndrome. 1,4 Underlining another condition where iron deficiency can have a significant adverse impact, 1 Nick Hartshorne-Evans, Founder and CEO of the Pumping Marvellous Foundation commented: "Iron deficiency in conditions such as heart failure is a very serious and real problem. It seems according to recent research that as many as one in two people with heart failure may have iron deficiency. Events such as Iron Deficiency Day 2017 are important in raising awareness of iron deficiency and its impact." The tools available on irondeficiencyday.com include a new symptom browser, visual infographics and advice for people, encouraging them to discuss iron deficiency with their physician. FURTHER INFORMATION
About Iron Deficiency Day 2017
About iron deficiency
As well as being a nutritional problem in the developing world, 12 iron deficiency occurs frequently in the developed world especially among women who suffer with heavy menstrual bleeding, the elderly and those with certain chronic diseases. 1 Iron deficiency is estimated to affect 37-61% of patients with chronic heart failure (CHF), 24-85% of patients with chronic kidney disease (CKD) and 13-90% of patients with inflammatory bowel disease (IBD). 1 Vifor Pharma Group , formerly Galenica Group , is a global specialty pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is the partner of choice for specialty pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma, a joint company with Fresenius Medical Care; Relypsa; and OM Pharma. Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348). For more information, please visit www.viforpharma.com. Vifor Pharma , a company of the Vifor Pharma Group, is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription and non-prescription medicines. Vifor Pharma's operational headquarters are in Zurich, Switzerland, and the company has an increasingly global presence and a broad network of affiliates and partners around the world. For more information about Vifor Pharma, please visit www.viforpharma.com . References
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Vifor Pharma Ltd. via GlobeNewswire
HUG#2151475
|
|||||||||||||||||
|
|||||||||||||||||
Copyright 2017 Nasdaq / GlobeNewswire | Back to overview list |